Your browser doesn't support javascript.
loading
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.
Dang, Chau; Ewer, Michael S; Delaloge, Suzette; Ferrero, Jean-Marc; Colomer, Ramon; de la Cruz-Merino, Luis; Werner, Theresa L; Dadswell, Katherine; Verrill, Mark; Eiger, Daniel; Sarkar, Sriparna; de Haas, Sanne Lysbet; Restuccia, Eleonora; Swain, Sandra M.
Afiliação
  • Dang C; Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Ewer MS; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Delaloge S; Department of Medical Oncology, Institut Gustave Roussy, 94805 Paris, France.
  • Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, University Côte d'Azur, 06110 Nice, France.
  • Colomer R; Division of Medical Oncology, Hospital Universitario La Princesa, 28006 Madrid, Spain.
  • de la Cruz-Merino L; Department of Clinical Oncology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
  • Werner TL; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
  • Dadswell K; Global Product Development, Roche Products Limited, Welwyn Garden City AL7 1TW, UK.
  • Verrill M; Northern Centre for Cancer Care, Freeman Hospital, Newcastle-upon-Tyne NE7 7DN, UK.
  • Eiger D; Product Development Oncology, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
  • Sarkar S; External Business Partner, Roche Products Limited, Welwyn Garden City AL7 1TW, UK.
  • de Haas SL; Oncology Biomarker Development, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
  • Restuccia E; Product Development Oncology, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
  • Swain SM; Georgetown University Medical Center, Lombardi Comprehensive Cancer Center and MedStar Health, Washington, DC 20007, USA.
Cancers (Basel) ; 14(11)2022 May 24.
Article em En | MEDLINE | ID: mdl-35681574

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos